Recently, Guoruitai Company, a subsidiary of Guoyao Engineering, successfully won the bid for the water injection system and clean pipeline engineering system project of Hebei Kaiwei Kangling Pharmaceutical Co., Ltd. with rich experience in fluid design and project implementation.

hebei kaiwei kangling pharmaceutical limited company is a wholly owned subsidiary of hebei kaiwei pharmaceutical limited company, kaiwei pharmaceutical is a rapid development of chinese pharmaceutical enterprises, long focused on the production and sales of small volume injection. Since its establishment, Kaiwei Pharmaceutical based in Zhangjiakou, has been committed to the production and supply of high-quality drugs with competitive prices, focusing on small-volume injections.( water needle) the newly built high-level injection production line has been passed through China. CFDA, Uganda NDA and other international regulatory organizations GMP

The scope of the contract signed between Sinopharm Guoruitai and Kaiwei this time includes the design and implementation of the liquid distribution system, purified water system, water for injection system and air pressure nitrogen system, and is required to meet the requirements of China. GMP the European Union, FDA the completion of the project will greatly enhance the continuous innovation and profitability of Kaiwei Pharmaceuticals.

(Contributor from Guoruitai Company)